Kramp et al., 1979 - Google Patents
Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccinesKramp et al., 1979
View PDF- Document ID
- 1581345499226250598
- Author
- Kramp W
- Six H
- Drake S
- Kasel J
- Publication year
- Publication venue
- Infection and Immunity
External Links
Snippet
Liposomal Enhancementof the Immunogenicity of Adenovirus Type 5 Hexon and Fiber
Vaccines Page 1 Vol. No. INFECTION AND IMMUNITY, Aug. 1979, p. 771-773 0019-9567/79/08-0771/03$02.00/0
Liposomal Enhancementof the Immunogenicity of Adenovirus Type 5 Hexon and Fiber …
- 229960005486 vaccines 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Perrin et al. | Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre-and post-exposure protection studies | |
| US9486510B2 (en) | Method to enhance an immune response of nucleic acid vaccination | |
| CA1243954A (en) | Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine | |
| CN102227442B (en) | Cytotoxic T cell epitope peptide of SARS coronavirus and application thereof | |
| AU631377B2 (en) | Affinity associated vaccine | |
| US5834015A (en) | Protein-lipid vesicles and autogenous vaccine comprising the same | |
| EP0634937B1 (en) | Vaccines containing non-ionic surfactant vesicles | |
| Garcon et al. | Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens | |
| De Haan et al. | Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice | |
| CN111375055A (en) | 2019-nCoV subunit vaccine composition and immunization method thereof | |
| JPH06500128A (en) | Immune stimulating and immunoenhancing reconstituted influenza virosomes and vaccines containing the same | |
| JP2001501640A (en) | vaccine | |
| CA2169297C (en) | Protein- or peptide-cochleate vaccines and methods of immunizing using the same | |
| EP0356340B1 (en) | Affinity associated vaccine | |
| CA1079634A (en) | Antigens bound to exterior surface of microvesicles | |
| Kramp et al. | Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines | |
| US5897873A (en) | Affinity associated vaccine | |
| US20110177163A1 (en) | Compositions and methods for treating hepatitis a | |
| Gerlier et al. | Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen. | |
| Allison | Adjuvants and immune enhancement | |
| AU7300091A (en) | Lfa-3 as a vaccine adjuvant | |
| JP3396478B2 (en) | vaccine | |
| Gregoriadis et al. | Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen | |
| WO2020121062A1 (en) | Methods of improving efficacy of allergy vaccines | |
| WO1990001947A1 (en) | Affinity associated vaccine |